Merck Tbk. vs Solusi Bangun Indonesia Tbk. — how do they compare? Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume), while Solusi Bangun Indonesia Tbk. trades at Rp775 (market cap 6.99T). The key difference: Solusi Bangun Indonesia Tbk. is far larger — about 4× Merck Tbk.'s market cap. Which is the better fit depends on your goals.
| MERK | SMCB | |
|---|---|---|
Market Cap | 1.76T | 6.99T |
Volume | 63K | — |
Lot | 630 | — |
Turnover | 243.97M | — |
Average Price | 3,872.46 | — |
Value | 243.97M | — |
Indicative Equilibrium Price | 3,900 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.
Read more on SMCB →